Vontobel Holding’s Rallybio RLYB Stock Holding History

Vontobel Holding’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-43,994	Closed	-$1M	–	1143
2023 Q1	$1M	Hold	43,994	–	–	0.01%	592
2022 Q4	$1.16M	Buy	+43,994	New	+$1.3M	0.01%	535

Other funds holding RLYB

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

New Leaf Venture Partners New York $43M AUM 33.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor San Francisco, California $252M AUM 45.72% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 107.05% 1-Year Est. Return

Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vontobel Holding's RLYB Position: Q2 2023 in Review

Vontobel Holding sold out of Rallybio (RLYB) in Q2 2023, closing a stake of 43,994 shares — an estimated $1M sold.

Vontobel Holding first reported a position in RLYB in Q4 2022 and held it in 2 quarters. The position peaked at $1.16M in Q4 2022. 59 funds tracked by Wall St. Rank hold RLYB as of Q2 2023.

Vontobel Holding reported no remaining Rallybio position as of Q2 2023 after selling out during the quarter.
Vontobel Holding sold 43,994 Rallybio shares in Q2 2023, an estimated $1M.
Vontobel Holding first reported a position in Rallybio in Q4 2022 and held it in 2 quarters.
Vontobel Holding's Rallybio position peaked at $1.16M in Q4 2022.
59 funds tracked by Wall St. Rank held Rallybio as of Q2 2023.

Based on Vontobel Holding's 13F filing for Q2 2023, filed 24 Jul 2023.